排序方式: 共有23条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Roberto Ferrari Claudio Ceconi Salvatore Curello Anna Cargnoni Evasio Pasini Odoardo Visioli 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1991,5(Z2):277-287
Reperfusion is the prerequisite for the ischemic myocardium to recover its metabolic and mechanical function. However, reperfusion
after a prolonged period of ischemia in the experimental animal may exacerbate, or at least accelerate, the occurrence of
ischemic injury, whilst in humans at the least it is not beneficial. This entity has been called reperfusion damage, since
much of the damage is believed to be caused by events occurring at the moment of reperfusion rather than by changes occurring
during ischemia. The existence of reperfusion damage, however, has been questioned, and evidence in favour of the concept
is sparse. At the moment the molecular events occurring at the time of reperfusion are not completely understood, and the
relative importance of several proposed deleterious mechanisms is not yet established. One of the most fashionable ideas for
the cause of reperfusion damage is that the function of cell membrane is modified by oxygen radicals generated at the moment
of reperfusion. Evidence in favour of and against this hypothesis is described in detail in the present article. 相似文献
5.
Francesco Marchesi Natalia Cenfra Lidia Altomare Maria L. Dessanti Sergio Mecarocci Elisabetta Cerchiara Angela Rago Mariella D'Andrea Valeria Tomarchio Odoardo M. Olimpieri Maria C. Tirindelli Andrea Mengarelli Maria C. Petti Guiseppe Avvisati Guiseppe Cimino 《Journal of Geriatric Oncology》2013,4(3):242-248
ObjectiveThe clinical outcome of elderly (≥ 75 years) patients with aggressive B-cell non-Hodgkin lymphoma (B-NHL) is not firmly established because few studies have specifically addressed this issue. In addition, the usefulness of a comprehensive geriatric assessment (CGA) in B-NHL still needs to be deeply explored.Materials and MethodsWe evaluated the prognostic factors of 73 patients aged ≥ 75 years (median age: 78) with B-NHL treated by clinical judgment with curative anthracycline-based approaches (n = 36) or with conservative treatments without anthracyclines (n = 37). Analysis of clinical outcomes also included baseline CGA stratification.ResultsThe curative approaches resulted in a better clinical outcome than conservative approaches [overall response rate: 91.2% vs. 69.7%, P = 0.003; 2-year progression-free survival: 47.2% vs. 21.6%, P = 0.006; and 2-year overall survival (OS): 58.3% vs 24.3%, P = 0.003] with similar safety profiles. Independent of treatment type, patients classified as “fit” and “intermediate” by CGA presented with better OS compared to patients classified as “frail” (P < 0.001). Patients classified as “fit” and “intermediate” who were receiving curative treatments presented with a significantly better OS when compared with those treated conservatively on the basis of clinical judgment. A curative anthracycline-based therapy (P = 0.048), the response to treatment (P = 0.017) and a “frail” condition (P = 0.031) were the only factors affecting OS in multivariate analysis.ConclusionsPresent data indicates that even in elderly patients with B-NHL curative anthracycline-based therapies are more effective than conservative approaches. However, choice of treatment should rely more on objective than on subjective parameters. Therefore, further prospective trials are warranted to better define the CGA role in hematopoietic malignancies. 相似文献
6.
Prof. Roberto Ferrari Riccardo Raddino Claudio Ceconi Salvatore Curello Salvatore Ghielmi Odoardo Visioli 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1989,3(3):403-412
Summary To assess whether pretreatment with the calcium antagonist anipamil protects the heart against ischemic and reperfusion damage and to establish how long the protection persists after cessation of the therapy, rabbits were injected subcutaneously twice daily for 5 days with 2 mg/kg body weight of this drug. The heart was then isolated 2, 6, or 12 hours after the last injection and was perfused by the Langendorff technique during a control period and 90 minutes of total ischemia (37°C), followed by 30 minutes ofreperfusion. Diastolic and developed pressure was monitored; coronary effluent was collected and assayed for creatine phosphokinase (CPK); mitochondria were harvested and assayed for respiratory activity, ATP production, and calcium content; and tissue concentration of adenosine triphosphate (ATP) and creatine phosphate were determined. The data obtained with anipamil were compared with those obtained with verapamil administered to the rabbit at the same dose and following the same procedure.Pretreatment with anipamil induced a negative inotropic effect under normoxic conditions; reduced the rate and extent of depletion of ATP and creatine phosphate during ischemia, with an incomplete restoration of the nucleotides after reperfusion; maintained mitochondrial function and calcium homeostasis during ischemia and reperfusion; reduced the rate of CPK release; and improved the recovery of ventricular function on reperfusion. The protective effects of anipamil persisted for as long as 12 hours after the last administration. In contrast, the protective and negative inotropic effects of verapamil were no longer apparent in heart isolated 6 or 12 hours after the last dose of the drug.It is concluded that anipamil pretreatment provides a protection against some of the deleterious effects of myocardial ischemia and reperfusion and that this effect is substantially longer than that of verapamil. The protective effect of anipamil (like that of verapamil) is probably secondary to a reduction of the rate of ATP hydrolysis during ischemia, although alternative mechanisms of action cannot be excluded. 相似文献
7.
Dr. Raffaele Giubbini Marco Metra Paolo Guerra Giovanni La Canna Giovanni Bissoli Giovanni Arosio Luigi Niccoli Odoardo Visioli Maurizio Bestagno 《European journal of nuclear medicine and molecular imaging》1987,13(5):213-220
Rest and exercise radionuclide ventriculograms were performed in 61 non infarcted, male, patients who underwent cardiac catheterization for chest pain and in 16 normal control subjects. Studies were performed using the first pass method with a fast single crystal gamma camera, which allowed a count rate of 140±19 Kcounts/sec to be reached during left ventricular filling; the count integral on left ventricular area was 10.8±1.6 Kcounts and the maximum count/pixel 155±16. We analyzed sensitivity, specificity, positive and negative predictive value of global ejection fraction (EF) and of the regional wall motion in identifying ventricular function abnormalities due to obstructive coronary artery disease. The regional wall motion was evaluated with four functional images: regional ejection fraction (REF), amplitude (A) and phase (PH) from Fourier analysis and systolic transit times (TT). Sensitivity was near 90% for EF, REF, A and TT, while PH was less sensitive (80%); all functional images were more specific (nearly 90%) than EF (80%). Both sensitivity and specificity were lower for the exercise EKG (59% and 63%, respectively) in this patient group. Significant differences between single vessel and multiple vessel disease were also observed either for the EF increase/decrease (-1.34±7.4 and-7.82±9.96; P<0.05) or for the number of segments which developed wall motion abnormalities during exericise (1.22±0.73 and 2.15±1.04; P<0.02). In conclusion, with our method, a fast single crystal gamma camera is suitable for obtaining optimal first pass radionuclide ventriculograms with a count density sufficient either for global or regional left ventricular function evaluation. First pass radionuclide ventriculography seems to provide very high diagnostic accuracy in the detection of cornorary artery disease in non infarcted, male, subjects. 相似文献
8.
9.
10.
Odoardo Tofanetti Ennio Cavalletti Adriana Besati Graziella Pratesi Gabriella Pezzoni Franco Zunino 《Cancer chemotherapy and pharmacology》1985,14(3):188-193
Summary The effect of reduced glutathione on acute lethal toxicity and urotoxicity induced by cyclophosphamide was studied on both mice and rats. The results of this investigation indicate that reduced glutathione is an effective protective agent against bladder damage from treatment with the alkylating agent. The timing of glutathione administration (IV) with respect to cyclophosphamide treatment influenced the uroprotective efficacy of the thiol compound. A schedule-dependent protective effect of glutathione against acute lethal toxicity of the antitumor drug was also observed. This partial protection was accompanied by a reduction in body weight loss following cyclophosphamide treatment. The therapeutic activity of cyclophosphamide on two experimental tumor systems (L1210 and Gross leukemia) was not impaired by combined treatment with glutathione, even at a relatively high dose of glutathione compared with cyclophosphamide. 相似文献